Trial reportFrontiers in medicine2026
Dexmedetomidine for improving postpartum sleep quality following cesarean section in women: a randomized controlled trial.
Trial report in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Perinatal sleep disturbance is highly prevalent among women undergoing elective cesarean section. Dexmedetomidine has been proven effective in improving sleep quality in patients undergoing general surgery, and this study aimed to investigate its potential efficacy in improving postoperative sleep quality in the elective cesarean section population. Methods: A total of 68 parturients scheduled for elective cesarean section were randomly allocated to the dexmedetomidine group (Group D) and the control group (Group C). Following fetal delivery, Group D received an intravenous bolus infusion of 0.5 μg/kg dexmedetomidine within 15 min, while Group C was administered an equal volume of normal saline as a control. Outcome measures included sleep quality scores at 1st, 2nd, 3rd day and 6th week postoperatively, STAI score at 1st, 2nd and 3rd day postoperatively, resting and activity-related pain scores at 24 h postoperatively, 24-h consumption of patient-controlled PCEA, the incidence of intraoperative shivering, EPDS scores at 6th week postoperatively and NBNA scores within 24 h/48 h after surgery. All outcomes were systematically recorded and compared between the two groups. Results: Group D had significantly higher sleep quality scores than Group C at the first postoperative night and 6th week postoperatively ( Conclusion: For parturients undergoing elective cesarean section, intraoperative intravenous bolus infusion of dexmedetomidine exerts a positive effect on improving sleep quality at the first postoperative night and 6th week postoperatively, as well as reducing activity-related pain scores at 24 h postoperatively. Clinical trial registration: Chinese Clinical Trial Registry (ChiCTR2500106212) https://www.chictr.org.cn/showprojEN.html?proj=280761.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.